Crucial role of breast cancer tumor suppressor revealed

Key points
- A new study led by José Javier Bravo-Cordero, Spanish researcher at the Albert Einstein College of Medicine in New York, details how cells with low levels of the profilin 1 protein in breast tumours increase their capacity to metastasise and invade other tissues.
- In recent years, medical professionals have been greatly interested in the development of new treatments to combat the spread of cancer, which is the largest cause of death in patients with this illness.
- However, effective treatments have still not been developed to stop or prevent tumour cells spreading from their primary tumour, a critical step in the cancer reaching different organs during metastasis.
- Now, a new study published in the 'European Journal of Cell Biology' and led by José Javier Bravo-Cordero, a Spanish researcher working in the Albert Einstein College of Medicine in New York (USA), reveals how the profilin 1 protein intervenes in the formation of determining structures for the tumour invasion.
A new study led by José Javier Bravo-Cordero, Spanish researcher at the Albert Einstein College of Medicine in New York, details how cells with low levels of the profilin 1 protein in breast tumours increase their capacity to metastasise and invade other tissues.
In recent years, medical professionals have been greatly interested in the development of new treatments to combat the spread of cancer, which is the largest cause of death in patients with this illness.
However, effective treatments have still not been developed to stop or prevent tumour cells spreading from their primary tumour, a critical step in the cancer reaching different organs during metastasis.
Now, a new study published in the 'European Journal of Cell Biology' and led by José Javier Bravo-Cordero, a Spanish researcher working in the Albert Einstein College of Medicine in New York (USA), reveals how the profilin 1 protein intervenes in the formation of determining structures for the tumour invasion.
"To obtain this level of effectiveness the tumour cells form a subcellular structure called invadopodia (from the Latin invado, invade, and podio, feet; invasive feet) and they use it to spread towards other parts of the organism," explains Bravo-Cordero to SINC.
Using high resolution microscope techniques, the authors have been able to study the dynamics of the invadopodia in tumour cells which lack profilin 1, and describe their role and the route they regulate.
Therefore patients with breast cancer tumours show reduced levels of the protein profilin 1, which is related to an increase in the capacity of the human breast tumours to metastasise other organs.
"Surprisingly, the cells which lack profilin 1 show extremely invasive activity mediated by the invadopodia, compared to control cells. It is as if we had taken the brake off and lost control of the vehicle," describes the Spanish scientist.
What is more, adds Bravo-Cordero, "in the absence of profilin 1 the invadopodia are more aggressive when it comes to degrading the extracellular matrix and are highly invasive structures, which explains the high metastatic potential of these cells".
A crucial structure
The work, carried out with the collaboration of researchers from the University of Pittsburgh (Pennsylvania, USA), shows the importance of the internal structure of the invadopodia and the actin cytoskeleton (basically the scaffolding of eukaryotic cells) in their function, and how profilin 1 plays a vital role in its regulation.
"If we destroy the scaffolding, the structures do not form; in the same way if we are very efficient with the assembly of this scaffolding we can form structures that have more invasive capacity. These are the variables that we have to play with to stop invasive tumours, and profilin 1 regulates this balance," the expert points out.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsUnderstanding the role of androgen receptor signaling in breast cancer
The ovarian production of steroid hormones throughout a woman’s lifetime is ample and varied, with important changes during different life stages. Estrogens are the most prominent ovarian hormones in terms of their…
17 February 2012
NewsCirculating tumor cells not linked to survival in newly diagnosed inflammatory breast cancer
The presence of circulating tumor cells in the blood appears to have no relationship to survival in women who have just been diagnosed with inflammatory breast cancer, according to new research from Fox Chase Cancer…
12 December 2011
NewsTeam identifies new breast cancer tumor suppressor and how it works
Researchers have identified a protein long known to regulate gene expression as a potent suppressor of breast cancer growth. Their study, in the journal Oncogene, is the first to demonstrate how this protein, known as…


